Change Language
Gemcitabine Injection IP

Gemcitabine Injection IP

950 INR/Vial

Product Details:


Gemcitabine Injection IP Price And Quantity

  • 10 Vial
  • 950 INR/Vial

Gemcitabine Injection IP Trade Information

  • Cash Advance (CA) Cash in Advance (CID)
  • 1000 Vial Per Week
  • 4 Days
  • All India South India Central India West India North India East India Gujarat Karnataka Kerala Lakshadweep Mizoram Meghalaya Manipur Andhra Pradesh Bihar Chandigarh Daman and Diu Goa Jharkhand Odisha Punjab Assam Delhi Dadra and Nagar Haveli Andaman and Nicobar Islands Arunachal Pradesh Chhattisgarh Haryana Himachal Pradesh Jammu and Kashmir Madhya Pradesh Maharashtra Nagaland Rajasthan Sikkim Tamil Nadu Telangana Tripura Pondicherry Uttar Pradesh Uttarakhand West Bengal

Product Description

Gemcitabine is a chemotherapy medication used to treat various types of cancer, including pancreatic, lung, breast, ovarian, and bladder cancers, among others. It is administered intravenously as an injection.

When a prescription specifies "Gemcitabine Injection IP," it refers to Gemcitabine formulated for intravenous use, complying with the standards of the Indian Pharmacopoeia (IP). IP stands for "Indian Pharmacopoeia," which is a legally recognized book of standards published by the Indian Pharmacopoeia Commission.

Gemcitabine works by interfering with the DNA of cancer cells, preventing their growth and ultimately leading to cell death. It is typically administered under the supervision of healthcare professionals, and the dosage and administration schedule depend on factors such as the type and stage of cancer being treated, the patient's overall health, and other concurrent treatments.

As with any chemotherapy medication, Gemcitabine can cause side effects, which may include nausea, vomiting, diarrhea, fatigue, lowered blood cell counts (neutropenia, thrombocytopenia), and increased risk of infection, among others. Close monitoring by healthcare providers is essential during Gemcitabine treatment to manage potential side effects and adjust the treatment regimen as needed.

Here are some frequently asked questions (FAQs) about Gemcitabine Injection IP:

  1. What is Gemcitabine Injection IP?Gemcitabine Injection IP is a chemotherapy medication used to treat various types of cancer, including pancreatic cancer, lung cancer, breast cancer, and bladder cancer.

  2. How does Gemcitabine Injection IP work?Gemcitabine works by interfering with the process of DNA replication in cancer cells, ultimately leading to their death. It is a nucleoside analog, meaning it mimics the structure of nucleosides, the building blocks of DNA.

  3. What conditions does Gemcitabine Injection IP treat?Gemcitabine Injection IP is primarily used in the treatment of pancreatic cancer, both as a single agent and in combination with other chemotherapy drugs. It is also used in the treatment of non-small cell lung cancer, breast cancer, bladder cancer, and certain other types of cancer.

  4. How is Gemcitabine Injection IP administered?Gemcitabine Injection IP is administered intravenously (into a vein) by a healthcare professional in a clinic or hospital setting. The dosage and frequency of administration will depend on the patient's specific condition, medical history, and treatment plan.

  5. What are the common side effects of Gemcitabine Injection IP?Common side effects of Gemcitabine Injection IP may include nausea, vomiting, fatigue, loss of appetite, hair loss, flu-like symptoms (such as fever, chills, and muscle aches), and low blood cell counts (such as low white blood cell count, low red blood cell count, and low platelet count). It's important to report any side effects to your healthcare provider.

  6. Who should not take Gemcitabine Injection IP?Gemcitabine Injection IP may not be suitable for everyone. Patients with certain medical conditions, such as severe bone marrow suppression or a history of severe allergic reactions to Gemcitabine or any of its components, may not be able to take Gemcitabine Injection IP safely. It's crucial to inform your healthcare provider about your medical history and any medications you are currently taking before starting Gemcitabine Injection IP.

  7. Is Gemcitabine Injection IP safe during pregnancy and breastfeeding?Gemcitabine Injection IP may cause harm to a developing fetus and is not recommended for use during pregnancy. It is also not known whether Gemcitabine Injection IP passes into breast milk, so breastfeeding is typically not recommended while receiving treatment with Gemcitabine Injection IP. It's essential to discuss the risks and benefits with your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding.

  8. Are there any interactions with other medications?Gemcitabine Injection IP may interact with other medications, including other chemotherapy drugs and medications that affect kidney function. It's crucial to inform your healthcare provider about all medications you are taking, including prescription drugs, over-the-counter medications, vitamins, and supplements, to avoid potential interactions.

Enter Buying Requirement Details
Email Id
Mobile number

Other Products in 'Oncology Drugs & Injections' category

Back to top